COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley

The elderly are considered a high-risk group for severe outcomes and death from COVID-19 infection. Given the emergence of new COVID variants and the immunity provided by vaccines waning over time, booster doses of the vaccine have been advocated for those at risk to stay protected. This study aimed...

Full description

Bibliographic Details
Main Authors: Kai Wei Lee, Sook Fan Yap, Hooi Tin Ong, Sien Leong Liew, Myo Oo, Kye Mon Min Swe
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/3/268
_version_ 1797239107042148352
author Kai Wei Lee
Sook Fan Yap
Hooi Tin Ong
Sien Leong Liew
Myo Oo
Kye Mon Min Swe
author_facet Kai Wei Lee
Sook Fan Yap
Hooi Tin Ong
Sien Leong Liew
Myo Oo
Kye Mon Min Swe
author_sort Kai Wei Lee
collection DOAJ
description The elderly are considered a high-risk group for severe outcomes and death from COVID-19 infection. Given the emergence of new COVID variants and the immunity provided by vaccines waning over time, booster doses of the vaccine have been advocated for those at risk to stay protected. This study aimed to determine the factors associated with hesitancy toward the second booster of the COVID-19 vaccine among the elderly residing in residential care homes. A cross-sectional study was conducted in 24 residential care homes in the Klang Valley using a face-to-face interview questionnaire. The study population included individuals aged 60 and above who had been fully vaccinated against COVID-19 up to the first booster dose. Second-booster hesitancy was assessed using the Oxford Vaccine Hesitancy Scale with seven items, the aggregate score of which ranges from seven to thirty-five; the higher the score, the greater the level of hesitancy. Multivariate linear regression was employed to determine factors associated with second-booster hesitancy, and a <i>p</i>-value < 0.05 was considered statistically significant. Data from 401 elderly individuals were included for analysis. The mean score of the Oxford Vaccine Hesitancy Scale was 21.6 ± 7.2. Predictors of second booster hesitancy were identified. Age, Indian ethnicity, being a recipient of the Sinovac vaccine as the first COVID-19 booster, experiencing the death of close friends or immediate family members following COVID-19 vaccination, and negative messages (indicating that taking a booster dose is harmful) from caregivers, friends, or family members were found to be associated with an increased second-booster-hesitancy score. Conversely, positive messages (indicating that taking a booster is helpful) from the government and caregivers, friends, or family members were identified as predictors associated with a reduction in the second-booster-hesitancy score. While vaccines effectively combat severe COVID-19, the majority of the elderly hesitate before taking the second booster. Their hesitancy, rooted in the perception of a low self risk and reliance on protection from the initial doses, emphasizes the need for intervention by relevant bodies. Taking into consideration the risk, albeit relatively low, of potentially serious side effects following COVID-19 vaccinations, it is imperative that transparent, appropriate, and positive messaging regarding booster vaccines, particularly in the context of the elderly from residential care homes, be available. Encouraging this high-risk group to embrace the second booster aligns with the goal of maximizing protection within the vulnerable elderly population.
first_indexed 2024-04-24T17:46:16Z
format Article
id doaj.art-89a27ec7379443a9ae0f9b2726307004
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-04-24T17:46:16Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-89a27ec7379443a9ae0f9b27263070042024-03-27T14:06:59ZengMDPI AGVaccines2076-393X2024-03-0112326810.3390/vaccines12030268COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang ValleyKai Wei Lee0Sook Fan Yap1Hooi Tin Ong2Sien Leong Liew3Myo Oo4Kye Mon Min Swe5Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, MalaysiaDepartment of Pre-Clinical Sciences, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, MalaysiaDepartment of Pre-Clinical Sciences, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, MalaysiaSchool of Business and Economics, Universiti Putra Malaysia, Serdang 43400, MalaysiaDepartment of Population Medicine, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, MalaysiaSchool of Medicine, Newcastle University Medicine Malaysia, Iskandar Puteri 79200, MalaysiaThe elderly are considered a high-risk group for severe outcomes and death from COVID-19 infection. Given the emergence of new COVID variants and the immunity provided by vaccines waning over time, booster doses of the vaccine have been advocated for those at risk to stay protected. This study aimed to determine the factors associated with hesitancy toward the second booster of the COVID-19 vaccine among the elderly residing in residential care homes. A cross-sectional study was conducted in 24 residential care homes in the Klang Valley using a face-to-face interview questionnaire. The study population included individuals aged 60 and above who had been fully vaccinated against COVID-19 up to the first booster dose. Second-booster hesitancy was assessed using the Oxford Vaccine Hesitancy Scale with seven items, the aggregate score of which ranges from seven to thirty-five; the higher the score, the greater the level of hesitancy. Multivariate linear regression was employed to determine factors associated with second-booster hesitancy, and a <i>p</i>-value < 0.05 was considered statistically significant. Data from 401 elderly individuals were included for analysis. The mean score of the Oxford Vaccine Hesitancy Scale was 21.6 ± 7.2. Predictors of second booster hesitancy were identified. Age, Indian ethnicity, being a recipient of the Sinovac vaccine as the first COVID-19 booster, experiencing the death of close friends or immediate family members following COVID-19 vaccination, and negative messages (indicating that taking a booster dose is harmful) from caregivers, friends, or family members were found to be associated with an increased second-booster-hesitancy score. Conversely, positive messages (indicating that taking a booster is helpful) from the government and caregivers, friends, or family members were identified as predictors associated with a reduction in the second-booster-hesitancy score. While vaccines effectively combat severe COVID-19, the majority of the elderly hesitate before taking the second booster. Their hesitancy, rooted in the perception of a low self risk and reliance on protection from the initial doses, emphasizes the need for intervention by relevant bodies. Taking into consideration the risk, albeit relatively low, of potentially serious side effects following COVID-19 vaccinations, it is imperative that transparent, appropriate, and positive messaging regarding booster vaccines, particularly in the context of the elderly from residential care homes, be available. Encouraging this high-risk group to embrace the second booster aligns with the goal of maximizing protection within the vulnerable elderly population.https://www.mdpi.com/2076-393X/12/3/268elderlyCOVID-19 vaccinebooster hesitancyresidential care home
spellingShingle Kai Wei Lee
Sook Fan Yap
Hooi Tin Ong
Sien Leong Liew
Myo Oo
Kye Mon Min Swe
COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley
Vaccines
elderly
COVID-19 vaccine
booster hesitancy
residential care home
title COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley
title_full COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley
title_fullStr COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley
title_full_unstemmed COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley
title_short COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley
title_sort covid 19 vaccine booster hesitancy among the elderly in malaysian residential care homes a cross sectional study in klang valley
topic elderly
COVID-19 vaccine
booster hesitancy
residential care home
url https://www.mdpi.com/2076-393X/12/3/268
work_keys_str_mv AT kaiweilee covid19vaccineboosterhesitancyamongtheelderlyinmalaysianresidentialcarehomesacrosssectionalstudyinklangvalley
AT sookfanyap covid19vaccineboosterhesitancyamongtheelderlyinmalaysianresidentialcarehomesacrosssectionalstudyinklangvalley
AT hooitinong covid19vaccineboosterhesitancyamongtheelderlyinmalaysianresidentialcarehomesacrosssectionalstudyinklangvalley
AT sienleongliew covid19vaccineboosterhesitancyamongtheelderlyinmalaysianresidentialcarehomesacrosssectionalstudyinklangvalley
AT myooo covid19vaccineboosterhesitancyamongtheelderlyinmalaysianresidentialcarehomesacrosssectionalstudyinklangvalley
AT kyemonminswe covid19vaccineboosterhesitancyamongtheelderlyinmalaysianresidentialcarehomesacrosssectionalstudyinklangvalley